Molecular Diagnostics
Breast Cancer Subtyping Assay on Rapid MDx Platform to Deliver Fastest Time to Results
Biocartis Group NV and APIS Assay Technologies Ltd. have entered into a new partnership agreement for the development of APIS’ Breast Cancer Subtyping assay on Biocartis’ rapid and easy-to-use molecular diagnostics platform Idylla. More...07 Apr 2023
Blood-Based Biomarkers Detectable by Simple Blood Test Could Simplify Diagnosis of Alzheimer's
A new study has demonstrated that blood-based biomarkers for amyloid and tau are highly correlated with the established biomarkers used for Alzheimer's diagnosis. These blood-based biomarkers have also shown great diagnostic accuracy in distinguishing between normal and non-normal levels of amyloid and tau biomarkers. More...06 Apr 2023
Benchtop Automated ELISA Platform Achieves Consistent Biomarker Detection 
The Ella automated immunoassay instrument from Bio-Techne Corporation streamlines the laborious manual process associated with traditional immunoassays, delivering quicker results, increased lab efficiency and reduced human error. More...
06 Apr 2023
Next-Gen IVD LC-MS/MS System 5X More Sensitive for Quantifying Analytes in Saliva, Breath and Dried Blood Spots
An extremely compact and sustainable analytical instrument accurately quantifies trace analytes with outstanding precision. The powerful instrument can improve patient care, generate cost savings, and meet a laboratory's unique analytical workflow requirements with its vast array of customizable options. More...06 Apr 2023
Easy-to-Administer Blood Test Could Enable High-Risk Lung Cancer Screening
To overcome the limitations of traditional liquid biopsy approaches and increase global access to cancer screening, a non-invasive, blood-based assay is currently being developed utilizing innovative technology. More...05 Apr 2023
Real-Time Quick-Response PCR Test Marks First Real Innovation in Subtyping Breast Cancer in Decades
Accurately subtyping the tumor is a critical aspect of breast cancer treatment, but the process has remained largely unchanged for over 50 years and is susceptible to inaccuracies. Now, a new real-time quick-response PCR (RT-qPCR) test is set to usher in the first real innovation in subtyping breast cancer in decades. More...
04 Apr 2023
Testing for Biomarkers in Urine and Blood Can Predict Patient’s Risk of Developing Chronic Kidney Disease
In a new study that examined the long-term consequences of acute kidney injury in hospitalized patients, researchers have found that elevated levels of specific biomarkers in urine and blood can predict a patient's likelihood of developing chronic kidney disease. More...04 Apr 2023
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Human Estradiol Assay
Human Estradiol CLIA Kit
8-Channel Pipette
SAPPHIRE 20–300 µL
In Other News
Non-Invasive Diagnostic Test Improves Detection of Oral Cancer
Digital PCR Platform Harnesses Microfluidic Technology for Quantification of Genetic Targets
New Integrated PCR Solutions Offer Flexibility and Portability for Small Laboratories and On-Site Testing
Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment
Blood Test for Multiple Pathways Related to Alzheimer’s Could Enable Earlier and Less-Invasive Diagnosis
POC Test Detects Genetic Blood Disorders with High Accuracy
Non-Invasive Fecal DNA Test Accurately Detects Colorectal Cancer and Precancerous Lesions
Simple Blood Test Could Help Doctors Diagnose Heart Disease in Physician's Office
Serum Protein Test Can Predict Outcomes for Liver Failure Patients
Fully Automated Blood-Based Assays Measure Biomarker for Neurodegenerative Diseases within 35 Minutes
POC Fingerprick Test Identifies Both HIV-1/2 and Syphilis Antibodies from One Sample within 60 Seconds
Transformative NGS Innovation Expands Access to Genomic Testing for Tuberculosis Patients
Quick, Affordable Finger-Prick Test Diagnoses Common STI in Five Minutes
Automated Sample-to-Result PCR Test Enables Rapid Genotyping for Antiplatelet Therapy
Handheld Molecular POCT System Enables Rapid Onsite Testing at Hospital ERs and Clinics
Next Gen Technology Enables Robust, Straightforward and Flexible Molecular Diagnostics in Any Environment
Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting
First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer
Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision
Point-of-Care MDx System Enables Simple, Fast and Accurate Diagnosis in Near Patient Setting
Near-Patient Molecular Test Outperforms Other Rapid Measures for Sepsis Diagnosis
Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer
Simple, Inexpensive Genetic Test Can Identify MS Patients at Risk of Fatal Brain Infection
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
